We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Interactions Help Prevent Arterial Blockage

By LabMedica International staff writers
Posted on 17 Feb 2015
Print article
The protein alpha-1-microglobulin (A1M) helps to prevent development of arteriosclerosis by inhibiting the oxidation of LDL (low-density lipoproteins) that is induced by the combination of myeloperoxidase (MPO) and hydrogen peroxide.

MPO, a heme-containing enzyme that catalyzes the production of free radicals and hypochlorite, is released by neutrophils during the inflammatory response to bacterial infections. MPO-induced low-density lipoprotein (LDL)-oxidation in blood has been suggested as a causative factor in atherosclerosis. A1M, which binds and degrades heme, is a radical scavenger as well as a reductase. A model has been proposed in which A1M is described as a circulating “waste bin” which continuously removes free radicals and oxidizing agents, particularly heme, from the tissues. It is subsequently transported to the kidneys, where it is broken down. The protein is therefore believed to protect cells and tissues against the damage that is induced by abnormally high concentrations of free hemoglobin and/or reactive oxygen species.

Investigators at Lund University (Sweden) studied the interaction between A1M and MPO in an in vitro model system. They reported in the February 3, 2015, online edition of the journal Frontiers in Physiology that A1M was cleaved proteolytically, with formation of t-A1M, after exposure to MPO, and that t-A1M contained iron and heme-degradation products. The reaction was dependent on pH, time, and concentration of substrates and a pH-value around 7 was shown to be optimal for cleavage. Furthermore, A1M inhibited MPO- and hydrogen peroxide-induced oxidation of LDL.

Senior author Dr. Bo Akerstrom, professor of medicine at Lund University, said, "By studying and testing A1M's properties in relation to LDL and MPO, we discovered that A1M can clean and reduce oxidized blood fats from LDL, as well as taking care of the dangerous substances from MPO and breaking them down. This means that A1M protects against damage to the molecules that we know is a cause of atherosclerosis. The next step is animal experiments, as well as analysis of human tissues. We want to study the blood to see if there is a link between the level of A1M, the concentration of oxidized blood fats, and the development of atherosclerosis. If this correlation exists, which I believe it does, I can imagine that it will be possible in the future to develop a preventive drug that reduces the risk of atherosclerosis. It is not impossible that future patients could receive one dose of A1M per month to clean the blood vessels."

Related Links:

Lund University


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.